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Colloidal semiconductor quantum dots are novel materials whose electronic and
optical properties can be greatly enhanced from the bulk semiconductor proper-
ties by quantum conﬁnement. A brief introduction to colloidal quantum dots and
the eﬀect of size on its electronic and optical properties will be given. CdSe/ZnS,
PbS, and PbSe quantum dots will be described in more detail with regards to the
research done in this dissertation. CdSe/ZnS quantum dots have luminescence
that can be tuned in the visible, making them particularly suited for ﬂuorescent
labels in biological applications. In particular, their potential use as voltage sen-
sors to detect cell membrane potentials and sphingosine phosphorylation will be
discussed. PbS and PbSe quantum dots emit in the near infrared, wavelengths
that are important to telecommunications. Their small third-order nonlinearity
and relatively long (microsecond) lifetimes will be discussed in terms of dielectric
screening. Fluoresence resonant energy transfer between PbS quantum dots will
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ixCHAPTER 1
INTRODUCTION
1.1 Colloidal Semiconductor Nanocrystals
Colloidal semiconductor nanocrystals or quantum dots are small pieces of semi-
conductor that are large enough to still have a crystal lattice but small enough
to exhibit quantum conﬁnement eﬀects. Small enough is determined by the Bohr
radius of the electron and hole of the bulk semiconductor. The electronic and
optical properties begin to change once the size of the nanocrystal becomes small
enough to conﬁne the electron or hole.
Semiconductor quantum dots are usually one of two types. Epitaxial quantum
dots are grown or patterned on a surface. Colloidal quantum dots are grown in
solution from precusors. This thesis will only deal with colloidal quantum dots.
There are numerous ways to grow quantum dots in solution. The dots used in this
thesis are grown by the injection of organometallic reagents into a hot coordinating
solvent. This causes immediate nucleation. The quantum dots continue to increase
in size due to the process of Ostwald ripening (smaller nanocrystals are more
likely to disolve than the larger ones due to higher surface free energy). The size
is determined by when the growth is stopped. This process however does not
produce quantum dots of just one size. There is always a distribution of sizes. A
common distribution is 5%[1][2]. This distribution will cause the ensemble optical
properties to be inhomogenously broadened. Unfortunately, this inhomogenous
broadening greatly complicates extracting information on the quantum dots.
Figure 1.1 is a diagram of a general colloidal semiconductor quantum dot. The
nanocrystal has a crystal lattice and is often surrounded by optional capping layer
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Figure 1.1: Diagram of a general colloidal semiconductor quantum dot
that passivates the surface. Ligands surround the dot and make it soluble. The
ligands are also involved in the growth process, but after the growth they can be
exchanged. The usual ligand for the dots in this thesis is trioctylphosphine oxide
(TOPO), which is soluble in only nonpolar organic solvents. To make the dots
water-soluble, the ligands can be exchanged with water-soluble ligands such as
oligomeric phosphines[3] or dihydrolipoic acid[4]. Though not shown in the ﬁgure,
the quantum dots can also be further encapsulated by amphilic molecules. This
will be discussed later in the thesis. Note not all colloidal quantum dots are exactly
like the ﬁgure. The ones studied in this dissertation are.
Theoretical calculations by Efros and Efros[5], Brus[6], and Schmitt-Rink[7]
provide a description of the eﬀects that quantum conﬁment have on the electronic
and optical properties of the nanocrystal. By conﬁning the electron or hole, their
energy levels are increased and quantized. A simplistic way to view the electronic
states of a quantum dot is to ﬁrst think of the electronic structure of an ideal3
D
e
n
s
i
t
y
 
o
f
 
S
t
a
t
e
s
Energy
Ideal Bulk Semiconductor
Ideal Quantum Dot
Figure 1.2: Density of states for an electron in an ideal bulk semiconductor (top)
and an ideal quantum dot (bottom)
semiconductor. Free electrons in an ideal semiconductor have their energy given
by E ∼ ¯ h2
2me
³
k2
x + k2
y + k2
z
´
. The k values are quantized to be an integer multiple
of π
L for a semiconductor in an inﬁnite potential (or 2π
L if using periodic boundary
conditions), where L is the length of the semiconductor. For a bulk semiconductor,
L is a macroscopic distance. Thus the energy levels are so closely spaced as to make
the energy almost a continuous function of k. This yields the familiar density of
states shown in the top of Figure 1.2 which is proportional to the square root of
the energy.
As L becomes smaller, the energy spacing becomes larger such that the energy
levels can no longer be considered continuous. The density of states then becomes
quantized as shown in the bottom of Figure 1.2. The smallest energy level, which
is given when the k values are the smallest nonzero multiple of π
L, also increases
by an amount of π2¯ h2
2mL2 from the bulk lowest energy level. The energy levels of the4
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Figure 1.3: Absorbance of a typical sample of PbSe quantum dots. The ﬁrst
exciton peak is clearly visible at 990 nm.
holes in the ideal semiconductor are quantized the same way , with mh, the eﬀective
mass of the holes, replacing me, the eﬀective mass of the electrons.
While this model is overly simplistic, it does explain the discreteness of the
states and the fact that the states become more separated as the size decreases,
and that the lowest energy level shifts on the order of L−2. While colloidal quan-
tum dots can be grown in many shapes, they are usually spherical in shape. All
the quantum dots in this thesis are spherical. Therefore the electronic states are
not labelled by cartesian quantum numbers, but by the spherical quantum num-
bers s, p, d, etc. Also, the energy levels have a small homogenous linewidth and
measurements of an ensemble of quantum dots also will have large inhomogenous
broadening due to the size distribution of the quantum dots.
Figure 1.3 is the absorbance of a typical sample of PbSe quantum dots studied
in this thesis. One can see discrete states in the absorbance, though they are5
clearly inhomogenously broadened. The lowest energy level is clearly seen and it is
labeled as the ﬁrst exciton peak. The ﬁrst exciton peak is the transition from the
unexcited state of the semiconductor to having one electron in the lowest electron
state, the se state and one hole in the lowest hole state, the sh state. Throughout
this thesis quantum dots will either be denoted by the peak of the luminescence or
the peak of ﬁrst exciton. For example the plots in later chapters that just denote
PbS quantum dots with 770 nm absorbance, imply that the quantum dots have
its ﬁrst exciton peak at 770 nm. It will of course have a very broad absorption.
Much more realistic treatments require knowledge of the actual band struc-
ture of the semiconductor. Therefore, while the semiconductor quantum dots will
all roughly have the general characteristics described above, the actual electronic
structure will diﬀer between each semiconductor. When dealing with the actual
electronic structure, semiconductor quantum dots are separated into three conﬁne-
ment regimes.
In the weak conﬁnement regime the size of the quantum dot is larger than
both the Bohr radius of the electron and the hole. The exciton created in this
type of quantum dot acts much like an exciton in the bulk. In the intermediate
conﬁnement regime, only the electron is conﬁned. When both the electron and
hole are conﬁned, both the electron and hole have their energy levels increased
and quantized. This is referred to as strong conﬁnement. Semiconductor quan-
tum dots with strong conﬁnement exhibit the greatest enhancement in optical
properties. Whether a semiconductor system can exhibit intermediate or strong
conﬁnement depends mainly on the properties of the bulk semiconductor, as the
smallest quantum dot that can be grown is still a few lattice constants in size. In
some semiconductors the Bohr radius for the electron or hole will be too small to6
be conﬁned in a quantum dot that can be realistically grown.
Quantum dots have many useful optical qualities. Because the states are quan-
tized, the dipole strengths are greatly increased from the bulk. Also, as long as
the surface of the quantum dot is well passivated such that there are no traps for
either electrons or holes, the quantum yield should be higher than in the bulk, as
the electron and hole can not drift away from each other as in the bulk.
Though the energy levels are quantized, there is still many of them. This gives
quantum dots a characteristically broad absorption. The quantum dots studied in
this dissertation all relax to the lowest energy state before emitting. This gives
them a characteristically narrow emission. While a broad absorption and nar-
row emission is similar to the bulk semiconductor, this property is quite diﬀerent
from usual ﬂuorophores such as dyes, As quantum dots are often compared with
ﬂuorophores such as dyes, it is important to note the diﬀerence.
Since the lowest energy level is determined by the conﬁnement, the emission
wavelength can be tuned by the size. This allows for semiconductor nanocrystals,
all of which have the same chemical composition, to span a wavelength range. The
long wavelength is determined by the bandgap of the bulk, though there is no
enhancement for dots that are this size. The short wavelength is determined by
the size necessary to make a crystal lattice, usually 1-2 nm[1].
There are many semiconductor systems that can be made into colloidal quan-
tum dots. In this thesis we will look at two diﬀerent wavelength regions. The
visible, which is useful for biological imaging, is covered by the CdSe quantum
dots. The CdSe quantum dots however only have intermediate conﬁnement. Only
the electron is conﬁned by the size. The hole is unaﬀected. It is common for the
CdSe quantum dots to have a ZnS cap to improve the quantum yield because of7
better surface passivation from the ZnS as opposed to the ligands.
The PbS and PbSe dots span the near-infrared which is the useful range for
telecommunications. Both the PbS and PbSe quantum dots are strongly conﬁned.
While PbSe can have a higher band gap semiconductor cap[8], in this work the
PbS and PbSe quantum dots without a cap are used.
1.2 Organization of the Dissertation
This dissertation is divided roughly into two parts. The ﬁrst discusses research
done with the CdSe/ZnS quantum dots. This part will include a quick intro-
duction along with attempts to put the quantum dots inside cell membranes and
model membrane systems in chapter two. Chapter three will include a part on the
encapsulation of the quantum dots with sphingosine in an attempt to detect phos-
phorylation of the sphingosine. The ﬁnal chapter on CdSe/ZnS quantum dots,
chapter four, will discuss a ﬁnal attempt at membrane potential detection and
conclude the work with CdSe/ZnS.
The second part discusses the research done with the lead salt, PbS and PbSe,
quantum dots. The ﬁfth chapter will pertain to measuring the nonlinearity of the
lead salts. After that the lifetime of PbS quantum dots will be discussed and the
implications for the dielectric screening model will be covered. Then ﬂuorescence
resonant energy transfer between the PbS quantum dots will be covered last of
all.CHAPTER 2
CDSE/ZNS QUANTUM DOTS IN BIOLOGY
2.1 Introduction
CdSe has a bulk bandgap of 730 nm[9]. Quantum conﬁnement can make the ﬁrst
resonance from the bulk all the way down to 400 nm [1][10][11]. This makes
them useful as ﬂuorophores for biological imaging [12][13][14]. As mentioned in
the introduction, the CdSe quantum dots do not exhibit strong conﬁnement. Only
the electrons are conﬁned by the quantum dot, not the holes. CdSe quantum dots
usually have a capping layer of ZnS. The ZnS passivates the surface better than
the ligand, and thus it increases the quantum yield. A diagram of a CdSe quantum
dot is in Figure 2.1.
CdSe/ZnS quantum dots have the characteristic narrow emission and broad
excitation of semiconductor nanocrystals. For comparison, in Figure 2.2 the exci-
tation and emission of green emitting CdSe/ZnS quantum dots is compared with
a standard dye, Rhodamine B. This fact, coupled with the fact that the emission
wavelength is tunable by size without changing the chemical makeup of the surface
or dot, make them ideal for multicolor imaging[15]. They have also been shown to
exhibit a large Stark shift[16][17][18][19].
To use quantum dots in biological applications, they have to be made water-
soluble. As made, the quantum dots are covered in a hydrophobic ligand, usually
trioctylphosphine oxide (TOPO). This ligand is used in the growth process and al-
lows the quantum dot to be soluble in nonpolar organic solvents. Early on, making
the quantum dots water-soluble proved to be quite diﬃcult. When this research
was started, this problem was just being solved. Quantum dots can be made
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Figure 2.1: Diagram of a CdSe/ZnS quantum dot
water-soluble by coating them in silica coat[12], exchanging the TOPO molecule
for a water-soluble ligand[13][4], or encapsulating the TOPO covered dot with an
amphilic polymer[20] or lipid[14]. The water-solubility issue is now considered
solved. Water-soluble CdSe/ZnS quantum dots are now commercially available.
Nonetheless, both organic-soluble quantum dots and water-soluble quantum dots
were studied. The quantum dots used in this chapter were provided by Marcel
Bruchez of Quantum Dot Corporation of Hayward, California.
2.2 Initial Characterization
Before research began into using the quantum dots as voltage sensors, an initial
characterization of the dots was performed. The CdSe/ZnS quantum dots have
been known to be bright ﬂuorescent biological labels[12][13]. Unfortunately, they
were also known to blink[21]. Their ﬂuorescence would turn on and oﬀ randomly
when excited. This property is undesireable especially in potential applications
that require single molecule tracking. These qualities of the quantum dot were10
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desired to be characterized with ﬂuorescence correlation spectroscopy (FCS). As
this initial characterization is already well reported in publication[22] and Dan
Larson’s thesis[23], only a summary of the results will be given here. Both the
organic-soluble and water-soluble dots were used in this study. The quantum dots
were made water-soluble by coating the dot with an amphilic polymer as described
in Reference [20].
FCS is a relatively straightforward experiment. A recent review of FCS is
given in Reference [24]. An optical focal volume of less than a femtoliter is setup
inside a solution containing the ﬂuorophores. The ﬂuorophores diﬀuse into and
out of the focal volume by Brownian motion. The experiment is setup such that
only ﬂuorophores that are in the focal volume are both excited and have their
ﬂuorescence collected. The data taken is just photons counted versus time. A
typical trace is shown in the top of Figure 2.3. The ﬂuctuations in the data
are mainly the eﬀect of diﬀusion. The actual FCS curve is just the normalized
autocorrelation of the photons counted versus time trace. A theoretical FCS curve
for a ﬂuorophore that experiences only simple diﬀusion is shown in the bottom of
Figure 2.3.
For the case of simple diﬀusion, the curve shown in bottom of Figure 2.3 indi-
cates two properties. The photons are only correlated for the time it takes for the
ﬂuorophore to diﬀuse through the focal volume. Thus by knowing the dimensions
of the focal volume, the diﬀusion coeﬃcient can be measured. Also the amount of
correlation is equal to 1/N where N is the number of emitting ﬂuorophores in the
focal volume. The concentration can then be determined. For the full theoretical
treatment see Dan Larson’s thesis[23] and references therein.
FCS can however show much more than just concentration and diﬀusion coef-12
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Figure 2.3: Top: Sample trace of photons counted versus time for a typical FCS
experiment. Bottom: Theoretical FCS curve for simple diﬀusion13
ﬁcients. Processes that aﬀect the ﬂuorescence of the particle that happen on time
scales smaller than the diﬀusion time scale can also be seen. Blinking, such as a
dye going into a non-emitting triplet state, can be seen if the blinking time (the
triplet lifetime in this case) is less than the diﬀusion time. This is because amount
of correlation, 1/N, is the number of emitting ﬂuorophores. If the ﬂuorophores can
go from a nonemitting state to an emitting state on a time scale smaller than dif-
fusion, then the amount of correlation will show that change. Photobleaching can
be seen as an excitation intensity dependent change in the apparent diﬀusion time.
There is no correlation between photons after a ﬂuorophore has been bleached as
well as when it diﬀuses out of the focal volume.
If the solution being studied is made of more than one ﬂuorophore, each with
greatly diﬀerent diﬀusion coeﬃcients, FCS will also be able to show this. This
was not an issue with this study of quantum dots, as the quantum dots did not
aggregate and were quite monodisperse. In the next chapter of this thesis, however,
single quantum dots will be encapsulated in lipid micelles to make them water
soluble. FCS serves as a great diagnostic in that case, as it can easily determine if
the micelle encapsulates just one quantum dot or many.
The FCS experiment provided signiﬁcant insight into the quantum dots. FCS
of the quantum dots showed an apparent concentration increase versus excitation
intensity. This was explained as an saturation of absorption which made the di-
mensions of the focal volume eﬀectively increase with excitation intensity. Equally
important is that FCS measured the diﬀusion of the quantum dots. The diﬀusion
measurements showed that the quantum dots had a much larger hydrodynamic ra-
dius than expected. In other words, quantum dots diﬀuse slower than hard spheres
of the same size. Quantum dots soluble in nonpolar organic solvents that were only14
5 nm in diameter have a 9 nm hydrodynamic radius. For water-soluble dots which
have an amphilic polymer layer over the TOPO ligands[20], the hydrodynamic
radius was 14 nm.
The hydrodynamic radius is signiﬁcant, not that the radius represents an actual
size, but that attaching the dots to biological molecules will aﬀect their movement
more than previously thought. It is also of note that the larger than expected
hydrodynamic radius had been mentioned in an early study by Mattoussi and
coworkers [25].
FCS also showed no blinking on the millisecond (diﬀusion) timescale in solution.
However, later research by others[26] indicated that conclusion to be incorrect.
The dots still blink even in solution. The reason for the diﬀerent conclusion as
explained by the researchers was that the autocorrelation function would not be
able to distinguish the blinking of quantum dots because the blinking has a power-
law distribution[27].
2.3 Membrane Potential Measurements
There is a desire in neuroscience to be able to do real-time imaging of electrical
signaling in cellular systems such as neurons. To do so, ﬂuorophores are required
that are bright, photostable, nontoxic, and have a large, fast change in ﬂuorescence
in the presence of an electric ﬁeld. A typical membrane is 4 nm across with a
maximum voltage of 100 mV. This means that the ﬂuorophore must be able to
have a measurable change in signal at 250 kV/cm. The change should also take
place in less than 1 ms. Voltage sensing ﬂuorophores usually fall into two categories.
One relies on molecular reorientation or redistribution in the presence of an electric
ﬁeld. This is slow process, but often produces very large shifts in ﬂuorescence[28].15
QD
Figure 2.4: Schematic of a quantum dot inside a lipid bilayer. Figure roughly to
scale.
The other rely on an electrochromic eﬀect that is fast, but often not very large[29].
2.4 Stark Eﬀect Measurements
Earlier studies by Colvin and coworkers [16][17][18] and Empedocles and coworkers
[19] indicated that the quantum dots have a large Stark Eﬀect. The Empedocles
study measured a quadratic luminescence shift for single CdSe/ZnS the order of 40
meV at 250 kV/cm. This study was with single dots on a glass slide at 10 K. Also
of note, Empedocles and coworkers measured this shift for CdSe dots with a ZnS
capping layer. One may have thought that the ZnS capping layer would provide
some screening of the electric ﬁeld and that was not the case.
Given the large measured Stark shift of the quantum dots, the purpose of our
study was to see if the quantum dots could detect changes in cellular membrane
potential. This required the solution to two distinct problems. First was whether
or not quantum dots could be put inside membranes. A typical membrane is only
4 nm thick, while a typical dot is around 5 nm in diameter not including the16
ligands. Figure 2.4 shows a diagram of the relative sizes of a quantum dot and
a lipid bilayer. Needless to say, a quantum dot will greatly perturb a biological
membrane.
The next question is whether the dots would still be sensitive to voltage changes.
The roughly 250 kV/cm maximum ﬁeld across a membrane is based on the roughly
100 mV potential over 4 nm. With the membrane perturbed to be almost 10 nm
thick with the dot, a reduction of 2.5 can be reasonably expected in ﬁeld. Also,
since the dots have to be modiﬁed to make them water soluble, there is a question
of whether that will cause screening eﬀects.
2.5 Black Lipid Membranes
The ﬁrst attempt to study these problems were with black lipid membranes (BLM)
[30]. Black lipid membranes are simple model membrane systems that are sus-
pended over a hole in a plastic sheet in salt water. Electrodes can be put in the
salt water on both sides of the membrane, and thus control the voltage across the
membrane. This system should allow the study of quantum dots in a bilayer.
The method is as follows. Egg Phosphatydilcholine acquired from Avanti Polar
Lipids was dissolved in decane. The plastic support was made of a thin peice
of polyethylene. A hole was made in the center by use of a hot (>100 C) needle
brought close, but without touching the plastic. The hot needle was removed when
the hole was just less than 1 mm in diameter as seen by eye. Then the plastic
support was immersed in salt water. The lipid decane mixture was “painted” or
spread over the hole. The lipid mixture then begins to thin to a bilayer.
Since quantum dots in their usual form are soluble in nonpolar organic solvents
such as decane, it was hoped that by putting the quantum dots in the lipid-17
decane mixture would protect them from the water. Water-soluble quantum dots
can’t be used, because they are surrounded by hydrophilic molecules, and would
immediately leave the bilayer. Quantum dots soluble in nonpolar organic solvents
can’t be put into the water after the BLM has thinned because the dots are very
hydrophobic and will immediately aggregate.
The end result, however, was that the lipid-decane-QD mixture when “painted”
over the hole in the plastic would not thin to a bilayer. Thus no membrane potential
experiment could be done. This work was done with the help of Professor Peter
Hinkle from the Molecular Biology and Genetics department at Cornell University.
2.6 Giant Unilamellar Vesicles
In the hopes that another model membrane system would work, the membrane
system of giant unilamellar vesicles was tried. A unilamellar vesicle is a single
lipid bilayer that has formed the shape of a sphere. The giant refers to it being
greater than 10 µm. The purpose was to try an experiment similar to that done
by Jerome Mertz and coworkers[31]. This involves putting a GUV between two
electrodes. An AC ﬁeld is put between the electrodes and due to the mobility of
ions inside the GUV near the bilayer, a ﬁeld is produced on certain parts of the
GUV. This is a much more complex experiment than the BLM.
GUVs were formed using either the method of electroswelling[32] or by the
method of hydration after evaporation[33]. The electroswelling method requires
drying lipids out in chloroform on large sheets of indium tin oxide (ITO). Then
placing the sheets of ITO together space about 1 mm apart and ﬁlling the area
with 50 mM sucrose solution. Then an AC ﬁeld of 2 V at 5 Hz is applied for 2 hours
and the GUVs form. The other method merely requires lipids to be evaporated18
in a Teﬂon or glass tube. Then they are slowly hydrated in a humid incubator at
37 C. The electroswelling method produced better vesicles in terms of uniformity.
The same issue of whether to use quantum dots that are soluble in nonpolar
organic solvents or water-soluble quantum dots is considered. Again since lipids
and quantum dots both dissolve in organic solvents, the method tried was to dis-
solve the quantum dots and lipids together in chloroform. The chloroform mixture
was then evaporated onto the ITO plates. The rest of the procedure was then
followed to try to form the GUVs. Unfortunately, while GUVs would form, none
of the quantum dots would be inside the bilayer of the GUVs. Because of this, the
experiment similar to Reference [31] was never setup or tried. This work was done
with the help of Tobias Baumgart of the Webb group.
2.7 Rat Basophilic Leukemia Cells and Gramicidin
Another attempt was made but now using an already stable cellular system. The
Rat Basophilic Leukemia (RBL) cells are a standard model cell that is easily grown
in Webb group lab. Upon introduction of gramicidin to RBL cells, their usually
large negative membrane potential quickly reduces to zero[34][35].
RBL cells were grown on thin plastic sheets in the Webb lab. After switching
the cells from a growth medium to Tyrodes buﬀer with glucose, the sheets were then
cut and put into a cuvette. The cuvette was placed in the sample compartment of a
PTI ﬂuorometer, and the ﬂuorescence was monitored. The dye used in References
[34][35], bisoxonol, was tried ﬁrst. Bisoxonol easily goes into the RBL membrane
after it is introduced into water. Unlike an organic-soluble quantum dot, it is
only slightly hydrophobic. Upon introduction of gramicidin to the RBL cells, the
ﬂuorescence of the bisoxonol greatly increased as expected.19
The water-soluble dots were used this time, as there was no way to get the
organic-soluble quantum dots into the RBL cells without them aggregating. While
it was realized that the water-soluble dots would not go into the membrane, it was
hoped that some would stick to the membrane and be close enough to be aﬀected
by the electric ﬁeld. This was not the case, the quantum dots had no aﬃnity
towards the cells.
2.8 Conclusion
The end result was that none of these methods worked. The model membrane
systems of the giant unilamellar vesicles and black lipid membranes would not
form with quantum dots in them. The RBL cells were very diﬃcult to get quantum
dots to stick to, and they did not show any sign of a ﬂuorescence change with the
addition of gramicidin. Possible reasons for this failure will be discussed in a later
chapter.CHAPTER 3
CDSE/ZNS QUANTUM DOTS FOR STUDIES OF SPHINGOLIPID
METABOLISM
3.1 Sphingolipid Metabolism
With the membrane potential measurements providing no results, a new idea was
set forth by professor David Russell of the Microbiology and Immunology depart-
ment of the College of Veterinary Medicine at Cornell. His idea was to encapsulate
quantum dots not in a bilayer, but in a spherical micelle. Then by changing the
charge on lipids encapsulating the quantum dot, perhaps the quantum dot would
have its luminescence shift due to the change in electric ﬁeld. Around the same
time a research paper was published by a Dubertret and coworkers at Rockefeller
University, that successfully encapsulated quantum dots in a spherical micelle with
a mixture of lipids to make the quantum dots water-soluble[14].
The lipids to be studied in this research were the sphingolipids. The sphin-
golipids are an important class of lipids involved in the signal transduction path-
ways that mediate cell growth, diﬀerentation, and death. Sphingosine is the most
common backbone of the sphingolipids, and the phosphorylation of sphingosine is
an important step in sphingolipid metabolism[36].
The speciﬁc process that is desired to be studied is the phosphorylation of
sphingosine into sphingosine-1-phosphate. Phosphorylation is the addition of a
charged phosphate group to a lipid. The phosphorylation of sphingosine requires
the enzyme sphingosine kinase and adenosine triphosphate (ATP). The enzyme
takes a phosphate group from the ATP and attaches it to the sphingosine. The
ATP becomes adenosine diphosphate (ADP) and the sphingosine becomes the
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Figure 3.1: Diagram of Sphingosine Phosphorylation
negatively charged sphingosine-1-phosphate. Figure 3.1 is a diagram of the process.
Figure 3.2 is diagram of a quantum dot with a phosphorylated sphingosine lipid
on it. The ﬁgure is roughly to scale. The electric ﬁeld from one charge at 10 nm is
roughly 140 kV/cm, which should large enough for the quantum dot to be aﬀected.
A key diﬀerence between this case and the membrane potential measurements is
that in this case the charges from phosphorylation may be uniformly spread across
the surface of the quantum dot as opposed to producing a electric ﬁeld across the
quantum dot as with the membrane.
The desired goal is to use encapsulated quantum dots as a monitor of the
enzyme activity . Once one has such a monitor, then one can conceivably study
such things as the time response of the enzyme and substances that may aﬀect the
activity of the enzyme.22
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Figure 3.2: Diagram of quantum dot with one sphingosine phosphorylated to
sphingosine-1-phosphate. Figure roughly to scale.23
3.2 Encapsulating Quantum Dots with Sphingosine
Dubertret and coworkers were able to encapsulate quantum dots in a mixture
of dipalmitoyl phosphatidylethanolamine-polyethylene glycol (DPPE-PEG) and
dipalmitolyphosphatidylcholine (DPPC). Both DPPE-PEG and DPPC are lipids
with fully saturated double hydrocarbon chains of 16 unit length. While they
tried several diﬀerent lipid combinations, they concluded that both the PEG and
a double hydrocarbon chain found on the DPPE were needed. However, a lot is
known about the self-assembly of lipids[37][38][39], and using that knowledge one
should be able to change the method of Dubertret and coworkers to use sphingosine.
There are three characteristics a lipid must have to form a micelle[37][38][39].
The ﬁrst is that the lipid must be amphilic, which means it must have both a
hydrophilic part, the polar headgroup, and a hydrophobic part, the hydrocarbon
chain. Since there is no chemical bond between the hydrocarbon chains, the hy-
drophobic part must be large enough to make the structure stable. Technically,
this means the lipid must have a low critical micelle concentration (CMC). The
CMC is the concentration at which the lipids will start to self-assemble into struc-
tures. If the concentration is below the CMC, the lipids will just exist separately
in solution.
The CMC is given generally by the equation CMC≈ exp[−(µ0
1 − µ0
N)/kBT].
The factor kBT is Boltzmann’s constant multiplied by the temperature. The con-
stant µ0
1 is the standard part of the chemical potential or the mean interaction
free energy per molecule for single molecules in solution. Likewise µ0
N is for the
aggregate of molecules, in this case a micelle. N is just the number of molecules
in the aggregate[37]. Unlike the diﬀerence between the chemical potentials, the
CMC is easily measured. Thus the discussion will use the CMC as the measure24
of stability or aﬃnity between the lipids, though there is no real chemical bond
or attractive force. The lower the CMC, the greater the diﬀerence between the
chemical potentials of the single molecule with respect to the micelle. This then
implies greater stability of the micelle structure.
The CMC of an amphilic molecule depends on the size of hydrophobic hydro-
carbon chains with respect to the size of the hydrophilic part. Lipids usually have
either one or two hydrocarbon chains. Those with two hydrocarbon chains have a
much lower CMC. Also by increasing the length of the chain, the CMC goes down
as well. For some typical numbers, a phosphatidylcholine (PC) with a double 5
unit hydrocarbon chain has a CMC of 90 mM. One with a double 10 unit chain
has a CMC of .005 mM. And a PC with just a single 10 unit chain has a CMC of
8 mM[40].
The second characteristic needed is that the lipid must also have the proper
packing geometry to form a micelle as opposed to other structures, such as the more
common bilayer. The measure used here is the critical packing parameter (CPP).
The CPP of a amphilic molecule is deﬁned as the volume (v) of the hydrocarbon
chains divided by the product of the area of the head group (a) and the length of
the hydrocarbon chain (l), or CPP= v/al. For a micelle to form, the CPP must be
at or below one third. This can be seen by just dividing the volume of a sphere by
its surface area and radius. For a bilayer, the CPP must be around one. Thus the
CPP is a measure of the curvature of the structure the amphilic molecule will form.
For example, if one wanted to encapsulate a sphere of diameter 5 nm with lipids
of hydrocarbon length 2 nm, the volume of the hydrocarbon chains would have to
be v = 4
3π((2.5 + 2)3 − 2.53). The surface area would have to be a = 4π(2.5 + 2)2.
This would require a molecule with a CPP of 0.62.25
The last characteristic is that there must be some sort of repulsive interaction to
keep the encapsulated dots from aggregating. It is important to note however that
the actual self-assembly dynamics are much more complex. This simple version
neglects several important properties. The phase transition temperature of the
lipids is an important property that is neglected. This aﬀects the volume of the
hydrocarbon chains. The eﬀect of salt and pH on the lipids is also important. Salt
can screen charges on the headgroups of the lipids which will decrease the surface
area of the head groups. Also changes in pH can actually change the charge on
the head groups as well. Also since the hydrocarbon chains aren’t rigid, the CPP
is not really an exact requirement. It is more of a guideline. However, this simple
version of self-assembly dynamics is more than good enough to provide a starting
point in picking lipids and rules of thumb in deciding how to adjust the procedure.
Often however, it is diﬃcult to have all the necessary characteristics to form
micelles with low CMCs met at the same time. For instance DPPC, which is one
of the shorter chain length components of GUVs, BLMs, and cellular membranes,
has a very low CMC, 4.6 × 10−10M [40]. This fact makes cellular membranes very
stable. Unfortunately, its geometry is such that it forms bilayers. Not surprisingly,
Dubertret and coworkers were unable to form micelles with DPPC alone. Usually
lipids that form micelles usually have either very short double hydrocarbon chains
or short single hydrocarbon chains, and therefore they usually have CMCs in the
millimolar range. DPPE-PEG is an exception as it has a long double hydrocarbon
chains that give it a CMC of 70 µM[41]. A mixture of DPPC and DPPE-PEG
will lower the CMC still, though it will increase the overall average CPP. As
previously calculated, the CPP for encapsulating a quantum dot (∼0.6) is more
than is required for a micelle (∼0.33), so the addition of DPPC should be beneﬁcial.26
The DPPE-PEG lipid also has the steric hindrance from the PEG. This keeps not
only biomolecules from sticking to the quantum dots, but also keeps the quantum
dots from sticking to each other.
When trying to encapsulate dots with sphingosine, diﬀerent lipids were tried
besides DPPE-PEG. It was feared that the steric hindrance of the PEG might
interfere with the enzyme. That concern coupled with an initial diﬃculty in getting
the DPPE-PEG/DPPC encapsulation to work, caused other lipids to be tried
ﬁrst. As seen in Figure 3.1 sphingosine has no real head group and is therefore
very hydrophobic. The quantum dots are covered with trioctylphosphine oxide
(TOPO), which is also very hydrophobic. TOPO has a triple hydrocarbon chain,
with each chain is 8 units long. Trying to encapsulate quantum dots in sphingosine
alone doesn’t work. The sphingosine and quantum dots just clump together and
aggregate out of solution. Therefore a mixture of lipids is required.
It is known that 12 unit single chain PC forms micelles[42] as well as 7 unit
double chain PC[43]. These would be the limit the lower end of the chain length,
as they have high CMCs and low CPPs. Due to price considerations, not all
lipid combinations can be tried and the PC lipids are often the cheapest. Since
the CPP of the encapsulating lipids should be higher than required for micelle
formation, slightly longer lipids can be used to lower the CMC. As for a repulsive
interaction, adding a small amount of charged lipids will keep the quantum dots
from aggregating. The charged lipids choosen where the phosphatic acid (PA)
lipids which are similar to the PC except they are missing the choline group (the
nitrogen and hydrocarbons) attached to the phosphate group making it negative,
and ethylphosphatidylcholine (EPC) which is PC with the phosphate neutralized
making it a positive lipid.27
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Figure 3.3: Chemical structure of the lipids used to encapsulate the quantum dots.
The appendix has the methodology and exact lipid combinations tried. Us-
ing just lysomyristoyl phosphatidylcholine (LMPC), dilauroyl phosphatidylcholine
(DLPC), dilauroyl ethylphosphatidylcholine (EDPLC), and dilauroyl phosphatic
acid (DLP A) with the sphingosine, quantum dots were successfully encapsulated
and made water-soluble. The LMPC is has single 14 unit hydrocarbon chain while
the DLPC, EDPLC, and DLP A have double 12 unit hydrocarbon chains.
Figure 3.3 shows the chemical structure of the lipids used. Sphingosine content
ranged from 5 to 90 percent. FCS was used to make sure that the prepared dots
were in fact monodisperse. Two such curves are shown in Figure 3.4. The fact that
the curves ﬁt a single diﬀusion curve and the hydrodynamic radius is similar to
quantum dots measured in the previous chapter, implies that they are in single dot
micelles and are not aggregated. Stability was never measured accurately . Quan-
tum dots encapsulated without a charged lipid would start to aggregate within
days. Quantum dots with charged lipid would last around 2 weeks. Therefore the28
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Figure 3.4: FCS curves of encapsulated dots. The ﬁt to a single diﬀusion curve
and the hydrodynamic radius imply that the dots are in single dot micelles, and
are not aggregated.29
quality of these dots are inferior to those produced by Dubertret and coworkers.
3.3 Sphingosine Phosphorylation Experiments
To test the dots for phosphorylation, the quantum dots were put in a ﬂuorometer
and their luminescence was monitored as enzyme and ATP were added. The
enzyme and ATP were provided by Roisin Owens of David Russell’s lab. The
data are in Figure 3.5. While no shift in ﬂuorescence was seen, the ﬂuorescence
intensity always decreased with ATP and the enzyme being added. Further tests
showed that the ﬂuorescence intensity only decreased when the enzyme was added
whether or not ATP was added at all. The ﬂuorescence was unchanged when just
ATP was added to the dots. Also the ﬂuorescence was decreased less for dots with
a larger percentage of sphingosine on them and for dots with a smaller percentage
of sphingosine on them. Therefore it seems as though the enzyme may be attaching
to the sphingosine, this in turn causes the sphingosine to be more likely to go into
solution and leave the dot. The quantum dot will lose ﬂuorescence yield as it
becomes unprotected.
3.4 Conclusion
After that point, experiments were stopped. It was decided that using the quantum
dots in this way wasn’t easy enough to continue. Russell’s lab which provided
the ATP and enzyme, had other methods to study the enzyme which were much
more likely to produce results. While in the end the experiment didn’t work, it
was an interesting study in self-assembly of lipids around quantum dots. If one
were to try again, serious consideration should be paid to trying to cross-link the30
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Figure 3.5: Data from the phosphorylation experiment. Top is data from dots
with 90% sphingosine. Middle is data from dots with 50% sphingosine. Bottom is
data from dots with 5% sphingosine.31
lipids so that they don’t come oﬀ the quantum dots. This will also improve the
stability. There are many ways to attempt this. There are polymerizable lipids that
upon exposure to ultraviolet light will cross-link[44]. There are also cross-linkable
polymers that can be used, as was done for making carbon nanotubes water-
soluble[45]. The overall mixture would not be fully biological, but that may not
matter. Another avenue to pursue is the phosphorylation and dephosphorylation
of other lipid systems. For instance there is an enzyme that removes the choline
group from PC to make it PA. The issue of whether the quantum dots will feel
the ﬁeld of charges spread uniformly around its exterior, is another question that
remains to be answered.CHAPTER 4
CDSE/ZNS QUANTUM DOTS IN BIOLOGY, CONCLUSION
4.1 Revisiting the Membrane Potential Experiments
Due to the work encapsulating the quantum dots with sphingosine, not realizing
the geometry considerations of the lipids while trying to get quantum dots into
membranes was a mistake. Trying to make GUVs and BLMs with the dots in the
lipid solution without altering the composition of the lipids will not work. The
usual procedure to make both GUVs and BLMs require the long double chain
lipids found in egg PC to make stable bilayers. To properly cover a quantum dot,
lipids with a low critical packing parameter (CPP) are required. However, it is not
clear that by altering the GUV or BLM lipid mixture with lower CPP lipids will
allow GUVs or BLMs to form with quantum dots in them. Another structure may
form instead. During the sphingosine experiments, when lipids with too large of a
CPP were used, bilayers with quantum dots in them did not form. What appeared
to be the encapsulation of two or more quantum dots in lipids seemed to be the
result. It just may not be favorable for bilayers to self-assemble around a quantum
dot.
However, if one prepared the bilayer system separately and the encapsulated
quantum dot system separately, one might be able to get the quantum dots into
the bilayer. To get the two together, an idea from drug delivery was borrowed.
Cell membranes are usually negatively charged. There are rarely any naturally
occuring positively charged lipids. A method in drug delivery is that a drug would
be encapsulated in a vesicle that had positively charged lipids[46]. These vesi-
cles would be attracted the cell membrane. They would bind and fuse together,
3233
emptying the contents of the vesicle into the cell.
The goal then is to encapsulate the quantum dots in lipids, some of which have
a positive charge. The DPPE-PEG/DPPC method was again not used, as the
PEG may interfere with the quantum dot getting to the membrane. In fact water-
soluble quantum dots from Quantum Dot Corporation were not used either. Those
dots, along with most other published methods of making water-soluble dots, are
made expressly to avoid sticking to membranes. They are meant to be attached
to a speciﬁc molecule only.
It was not diﬃcult to ﬁnd a mixture of LMPC, EDLPC, and DLPC that would
work. The EDLPC is a synthetic positively charged lipid. The actual method
is cover in the appendix. It is interesting to note that the addition of a little
(5 percent) sphingosine helped the encapsulation. Without it, there was a 4 nm
redshift in ﬂuorescence and a slight decrease in intensity. That seems to imply
that the lipid mixture is not well optimized and that the sphingosine helps ﬁll in
gaps and lowers the CMC.
4.2 The Aplysia experiment
To test this idea, another voltage sensing experiment was tried. The system used
was Aplysia neurons. Dan Dombeck of Webb group had this system setup, and
was very familiar with it. It is described well in his paper[47]. An Aplysia neuron
is voltage clamped, allowing the voltage across the membrane to be changed. The
system has the sensitivity to detect 1% per 100 mV with averaging. The only
modiﬁcation of his experiment is the change in detection. His setup detected
changes in second harmonic intensity versus voltage. As the quantum dots are
expected to shift their ﬂuorescence, not change their intensity, that setup wouldn’t34
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Figure 4.1: Picture ofAplysia labeled with quantum dots encapsulated with lipids.
work. Fortunately, his setup was easy to modify. The setup has two detectors. By
splitting the collected ﬂuorescence into the two detectors by means of a dichroic,
a shift in ﬂuorescence can be detected by a change in the ratio of the intensities
of the detectors. Thus the dichroic converts a ﬂuorescence shift into a intensity
shift, which is what the setup usually measures. A dichroic was chosen that split
the ﬂuorescence in the center of spectrum.
Encapsulated quantum dots were prepared the day before the experiment. The
dots were then introduced to the Aplysia neurons. No rinsing was performed.
Usually a rinse or wash is performed after a ﬂuorophore is added to cells, to
remove any free ﬂuorophore not attached. That was not needed, implying the dots
all stuck to the membrane. Figure 4.1 is a picture taken of a Aplysia used for the
measurement. One can see the clamp as it is the large straight piece coming from
the cell.35
While the fact that the quantum dots stuck to the membrane implied they were
attracted to the membrane, the experiment overall was a failure. No ﬂuorescence
shift could be seen with voltage change. Worse still, the quantum dots seemed
to lose ﬂourescence intensity quickly, implying that they were not stable. It is
also not certain that the dots were in the membrane, they may have just stuck to
it. Electron microscopy would have to be done to conﬁrm that. However, with
Dombeck’s work with second harmonic dyes to detect membrane potentials with
this system working so well, there was little interest in diagnosing the problems
and continuing the work.
4.3 Conclusion
CdSe/ZnS quantum dots are visible ﬂuorophores with broad excitation and narrow
emission. They also exhibit a Stark shift. The focus of this work was to exploit its
Stark shift to observe biologically relevant processes. The quantum dots proved
too diﬃcult to work with in comparison to traditional methods. This fact is why
it is diﬃcult to imagine that CdSe/ZnS quantum dots will replace traditional
ﬂuorophores in general. Only in a few cases will they perform so signiﬁcantly
better that they will be worth the eﬀort to get to work.
The property of broad excitation and narrow emission seems to be the most
exploitable, as dyes are not and can not be made to have this property. Any
experiment that requires multiple colors such as ﬂow cytometry and multichannel
FCS should beneﬁt greatly from this[15]. The barcoding applications that also
arise from this property will also be of great utility[48]. The applications that
require multiple colors seem to be the future of CdSe/ZnS quantum dots, not
applications that require its Stark eﬀect.36
If however, someone wished to continue this research there are some ideas to
be pursued. For the sphingosine lipids, the cross-linking lipids or amphilic poly-
mers should be investigated. Also using only core CdSe dots instead of core/shell
CdSe/ZnS dots may prove to be more sensitive. As for the membrane measure-
ments, the idea of ﬁrst making the dots water soluble separately from the mem-
brane system seems like the correct idea. With that in mind, it is probably wise
to go back to the model membrane systems such as the black lipid membranes.
The BLM system is quite robust and more importantly do not require growing
cell cultures which take a signiﬁcant amount of time. Cross-linking lipids for the
membrane system may not work, but also could be investigated.CHAPTER 5
NONLINEAR MEASUREMENTS OF PBSE QUANTUM DOTS
5.1 Introduction
The colloidal lead salt quantum dots are similar to the CdSe quantum dots in that
they have broad excitation and narrow emission. They are diﬀerent, however, in
that they are strongly conﬁned while the CdSe quantum dots are only intermedi-
ately conﬁned. This is because the Bohr radius of both the electron and holes are
quite large, 10 nm for PbS and 24 nm for PbSe[49].
While PbSe quantum dots have been made with a capping layer (PbSexS1−x)[8],
high quality lead salt quantum dots can be used without a capping layer similar
to ZnS for the CdSe quantum dots. The other major diﬀerence is the wavelength
of light at which they emit. The CdSe dots emit in the visible, while the lead salt
quantum dots emit in the near infrared. This is because the band edge for CdSe
is 730 nm while for PbS it is 3 µm and for PbSe it is 4.6 µm [9].
All but the smallest lead salt quantum dots are not useful in biology as water
becomes highly absorptive in the near-infrared. The near-infrared is however, the
wavelength range in which telecommunications are used. The major telecommu-
nications bands are at 1550 nm and 1300 nm. There is a great desire to get good
emitters, detectors, ampliﬁers, and optical switches in those wavelength ranges.
A general review of the electronic and optical properties of the lead salt quan-
tum dots is given in Reference [50]. More detailed theoretical calculations of the
lead salt quantum dots are given in References [51] and [52].
This study will concentrate on the third-order optical nonlinearity of the lead
salt dots for the potential use of optical switching. Based on data from CdSe
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Figure 5.1: Diagram of the z-scan experiment.
quantum dots[53][54][55], we expect that the lead salt quantum dots will also
have large a third-order optical nonlinearity. Also PbS quantum dots in glass
have already been shown to have saturable absorption and have been used for
that purpose in lasers[56][57][58][59]. The experiment we will use to measure the
nonlinearity is the z-scan.
5.2 The Z-scan
The index of refraction on a third-order nonlinear material can be written as
n = n0 + n2I, where n0 is the usual linear index of refraction and n2 is the
intensity dependent index of refraction representing the third-order nonlinearity.
For reference, fused silica which makes the optical ﬁbers that are the backbone of
telecommunications has a n2 = 3 × 10−16 cm2
W [60].
Because of the intensity dependence of the index of refraction, a beam with
enough intensity will acquire a phase front that is proportional to the beam shape.
Most beams are gaussian, and thus produce a gaussian phase front. This is very
similar to the eﬀect a lens has on a beam, though lens are spherical not gaussian
usually. If n2 is positive, the material acts as a focusing lens. If it is negative, the
material acts a defocusing lens.39
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Figure 5.2: Theoretical z-scan curves for both a positive and negative n2.
The z-scan experiment uses this property to determine n2[61]. A diagram of a
z-scan experiment is shown in Figure 5.1. It has a collimated beam incident on a
focusing lens. The beam goes through the sample at a position z which is varied.
After the sample there is a pinhole and a detector. When the sample is before
the focus and n2 is positive, the self-focusing of the sample will bring the overall
focus of the beam towards the lens. This makes the beam at the pinhole larger,
which lowers the detected intensity. After the focus the self-focusing property of
the sample will make the beam at the pinhole smaller. This increases the detected
intensity. The exact opposite of what was described happens if n2 is negative.
Theoretical curves of the z-scan are shown in the Figure 5.2. The detected
intensity which is also known as the intensity transmitted through the sample and40
aperature is denoted as T. The plot shows the normalized change in transmitted
intensity (∆T/T) versus the z position of the sample. The change, ∆T, is the
diﬀerence between detected intensity when the sample is at the current position
z and the detected intensity when it is at a position far from the focus. The
horizontal axis of the plot is normalized to the confocal parameter of the focused
beam, z0.
The z-scan is not a very sensitive way to measure n2. If the sample is non-
uniform, as the sample moves and the beam hitting the sample changes size, the de-
tected intensity will change without the nonlinearity just due to the non-uniformity.
A more sensitive measurement is spectrally-resolved two-beam coupling[62]. This
method works with femtosecond pulses when it is easy to resolve the spectrum
of the laser. Picosecond and longer pulses do not have the bandwidth to easily
spectrally-resolve energy shifts due to the nonlinearity. Long pulses were used in
this study because of the concern that large bandwidth pulses would not be able to
saturate the excited state of the quantum dots. The use of low peak power pulses
also lowers the sensitivity of the experiment.
5.3 The Samples
The samples were provided by Evident Technologies of Troy, New York. They were
provided in ﬁlms sandwiched between two glass slides. The samples were usually
labeled by their concentration before introduction to the host that comprised the
ﬁlm. Evident did not give speciﬁcs about how the ﬁlms were made and what exactly
the hosts were made of, so it is diﬃcult to infer much about the quantum dots
themselves. Several samples were given with diﬀerent ﬁrst exciton wavelengths.
The most used samples were one with a ﬁrst exciton wavelength at 1064 nm and41
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measurement.
another at 1550 nm. The quantum dots were put into ﬁlms that were around 100
µm thick at an intial concentration of 100 mg/mL. The 1064 nm sample was used
with a Nd:YAG Antares that was actively modelocked to produce 100 picosecond
pulses with 200 nJ at 1064 nm. The 1550 nm sample was used with a Coherent
Mira OPO system that produced 1 ps pulses with around 1 nJ of energy at 1550
nm. Both systems produce roughly the same order of magnitude peak power. Since
the 1550 nm sample is at the more relevant wavelength, the rest of the chapter
will deal with that sample. A plot with the absorption of the 1550 nm ﬁlm and
the spectra of the laser used to measure the sample is shown in Figure 5.3.42
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Figure 5.4: Sample z-scan data.
5.4 Experimental Results
A typical trace from the OPO experiment is shown in Figure 5.4. This shows a
large negative nonlinearity. The data is ﬁt using the equation from Reference [63]
for large nonlinearities:
∆T/T = 1 −
Ã
1 −
4x
(1 + x2)2∆Φ +
4
(1 + x2)3∆Φ
2
!−1
(5.1)
The x in the equation is z/z0. The confocal parameter, z0, is estimated by mea-
suring the beam width at several locations with a beam proﬁler and ﬁtting for the
beam width, w0. The confocal parameter is related by the equation z0 =
πw2
0
2λ . In
this case the confocal parameter is about 1.8 mm which corresponds to a beam
width of around 30 microns. The phase shift, ∆Φ, is equal to 2π
λ Ln2I, where I is
the intensity and L is the thickness of the ﬁlm. The fact that the curve doesn’t ﬁt
well in the wings may be because of the two pieces of glass that sandwich the ﬁlm43
of quantum dots.
Unfortunately after careful analysis, this nonlinearity is due solely to thermal
heating eﬀects. Since the quantum dots absorb the laser light, some excess energy
that is not emitted heats the sample. This causes a thermal gradiant that eﬀects
the index of refraction by changes in the density. This was ﬁrst suspected when the
repetition rate was reduced by an electro-optic modulator. Reducing the repetition
rate reduces the average power incident on the sample by reducing the number of
pulses hitting the sample, but does not change the peak power of the pulses.
Reducing the repetition rate to 1 MHz from the usual 76 MHz caused the signal
to disappear.
To further check the thermal nature of the z-scan result, a 30 hole chopper with
all its holes covered but one and a boxcar were used to gate the signal. The boxcar
was set to a 4 µs gate width and was scanned from when the chopper ﬁrst let the
pulses through (at 76 MHz repetion rate) to the time when the chopper closes. The
beam was focussed with a 5 cm lens into the chopper to shorten the time it takes
for the chopper to be fully open to the beam. The Figure 5.5 shows the peak of the
signal versus the time when the chopper is open. This plot clearly shows a millisec-
ond rise time indictative of a thermal nonlinearity. The thermal nonlinearity is not
useful because of this long rise time. Telecommunications need fast (femtosecond)
nonlinearities. While thermal nonlinearities have been studied[64][65], they give
information about the host such as the heat conductivity and the change of index
of refraction due to temperature. The thermal nonlinearity gives little about the
quantum dots, as one would get the same eﬀect from anything that produces an
equivalent amount of heat. As Evident Technologies did not give much information
on the host, there was little incentive to try to extract the host’s qualities.44
1 10 100 1000
Time from start of rise (ms)
0
0.05
0.1
0.15
0.2
D
T
/
T
p
e
a
k
DT/Tpeak     vs Time
Figure 5.5: Data of the peak change of transmittance of the z-scan versus time
from when the chopper opens and laser light is incident on the sample.
The existance of a large signal obscures the signal of interest, the nonlinearity
from the electronic response. One way to mitigate this problem is to directly
time-resolve the response of the nonlinearity using pump-probe techniques[66]. A
diagram of the setup is in Figure 5.6. Here the beam is ﬁrst split into two, a pump
and a probe. The pump usually has 95% of the energy. The pump beam put
through a half-wave plate to rotate the polarization by π/2 and into a variable
time delay. Then it is recollimated with the probe beam and put into the z-scan
setup. The sample is placed at a z position that should yield either a peak or a
valley. The time delay between the pump and probe is then swept and the probe
intensity is monitored. The pump beam is separated before the detector in the z-
scan by a polarizing optic. An electronic nonlinearity will have a near instanteous
rise time that should be clearly visible.45
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Figure 5.6: Diagram of the time resolved z-scan.46
Unfortunately, no signal could be seen at the maximum light level capable from
the OPO. An upper limit for the samples was put at 500 times the nonlinearity
of fused silica. Current large nonresonant(fast) nonlinear materials are already
available with this order of magnitude of nonlinearity [67].
5.5 Conclusion
Once the issue of the large nonlinearity due to thermal eﬀects was taken into
account, the electronic optical nonlinearity was too small to be measured. This
means that lead salt quantum dots are not suitable for applications such as optical
switching. A possible answer to why the nonlinearity is so small, will be discussed
in the next chapter. In principle, one could try again with a picosecond optical
parametric ampliﬁer, which would have roughly 1000 times the peak power of the
optical parametric oscillator. However, the isn’t any access to one at Cornell.CHAPTER 6
THE PHOTOLUMINSCENCE LIFETIME AND DIELECTRIC
SCREENING OF PBS QUANTUM DOTS
6.1 Introduction
The lead salts are highly polarizable. The dielectric constant for PbS is 17 while
for PbSe is 23. From Maxwell’s equations, the ﬁeld inside a sphere of dielectric
constant ²i is reduced from the ﬁeld outside of dielectric constant ²o by a factor
3²o/(²i + 2²o). For the usual solvents such as cholorform which has a dielectric
constant around 2, this can be a reduction factor of 4-5 for PbSe. If the ﬁeld
is reduced by that factor, then nonlinearities, which depend on the ﬁeld to the
4th power, will be reduced accordingly. This could explain the small nonlinearity
measured by the z-scan.
A way to check is to measure something that depends on the ﬁeld and change
the solvent. Guyot-Sionnest suggested that the dielectric screening eﬀect is the
reason why the quantum dots have longer lifetimes than theoretically expected
[68]. This was also mentioned in the works of Schmitt-Rink[7] and Allen and
Delerue[52]. Unlike the nonlinearity measurements, lifetime measurements are
much simpler to do. A change of lifetime versus solvent has already been seen in
the CdSe/ZnS quantum dots[69].
6.2 Lifetime Experiments
The lifetime of the PbS quantum dots were taken in a system originally put to-
gether from PicoQuant to do time-correlated single-photon counting. It amounts
to a sample chamber that allows laser light to come in from one direction. The
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Figure 6.1: Diagram of the experimental setup used to measure ﬂuorescent life-
times.
luminescence is collected at a right angle to the beam. The luminescence is then
put through a monochrometer into a detector. Figure 6.1 is a diagram of the ex-
perimental setup. Depending on the slit width, the monochromater could have
wavelength resolutions of 8, 16 or 32 nm. The smaller 0.5 mm slits were used in
most cases which gave the monochromater 8 nm resolution.
The excitation was a Clark MXR regenerative ampliﬁer capable of producing
400 µJ pulses at 800 nm at a 1 kHz repetition rate (400 mW average power).
This laser was used mainly because it had a low repetition rate which allowed the
sample to fully relax between pulses. The sample was only exposed to µW average
power levels so that the sample was always kept below one excitation per quantum
dot.
Detectors, especially single photon counters, have always been diﬃcult to obtain49
in the near infrared. They are usually plagued by noise and large dark counts. A
germanium avalanche photodiode (Ge APD) came with the PicoQuant system, but
had far too many dark counts, 103 counts/s. The best detector in the near infrared
is a silicon single photon counting APD. A Perkin-Elmer single photon counting
APD was attached to the lifetime setup. It has only 40 dark counts per second.
The output was then fed into a SRS430 multichannel scalar. Both the detector
and SRS430 were borrowed from Webb group. The silicon detector only can detect
out to 1100 nm in theory, but as it has very low dark counts it can detect out to
1150 nm and still have better performance than the Ge APD. Fortunately, PbS
quantum dots that emit below 1100 nm are commercially available. The SRS430
had minimum time resolution of 5 ns, which while large is much smaller than the
measured lifetimes. While it would be preferable to measure the PbSe quantum
dots used in the previous chapter, the PbS quantum dots are similar enough that
the conclusion drawn should apply to the PbSe quantum dots.
Two diﬀerent samples purchased from Evident Technologies roughly 2 months
apart. They were both PbS quantum dots with ﬁrst exciton peak at 770 nm and
center of emission at 920 nm. They were dispersed in either tetrachloroethylene
(TCE), chloroform, or hexane. TCE has an index of refraction of 1.50, while
hexane has an index of refraction of 1.38. Chloroform is in the middle with an
index of refraction of 1.44. None of the solvents have absorption resonances at
920 nm. Since TCE has the least contrast in dielectric constant with PbS, it is
expected to have the shortest lifetime. Hexane should have the longest lifetime.
The data from the two diﬀerent samples is shown in Figure 6.2. The data are
ﬁtted to a single exponential function, Aexp(−t/τL), where τL is the lifetime. The
data ﬁtting is weighted to the square root of the counts. This is the expected50
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Figure 6.2: Data showing the variation of lifetime versus solvent.51
error for a Poisson process. The data near the top of the curve is considered more
accurate than the data near the bottom and the ﬁtting uses this. Also data with
less than around 10 to 100 counts were neglected in the ﬁtting. The data with low
photon counts is suspect because of the inﬂuence of dark counts from the detector.
The lifetimes are oﬀset, but clearly show that the lifetime of the quantum dots
in TCE is indeed shorter than that from chloroform or hexane. However, using the
simple classical model of dielectric screening, the quantum dots in hexane should
have 30% longer lifetime than that of the TCE. The actual result is just below 20%.
This could because the index of refraction given is not at the correct wavelength.
Also the classical model may not apply exactly to quantum dot systems. The work
with the CdSe/ZnS quantum dots implied a nonclassical dielectric screening[69].
The models put forward in that paper though neglect the dielectric constant of
the CdSe, and also would give a much smaller variation with respect to index of
refraction than is observed in this experiment with the PbS quantum dots[69].
While both samples show the approximately correct dielectric screening, they do
not have consistent lifetimes. This indicates that quantum dots are not being
synthesized consistently as of yet. Nonetheless, for these dots the lifetime can
be said to be approximately 2 µs long. This is relatively consistent with earlier
measurements on colloidal PbS quantum dots which measured 1 µs lifetimes[70].
6.3 Fluorescence Resonant Energy Transfer
When the PbS quantum dots that were studied are dried into a close packed ﬁlm,
the luminescence red shifts from 920 nm by roughly 40 nm to 960 nm, as in Figure
6.3. It is believed that ﬂuorescence (or F¨ orster) resonant energy transfer (FRET)
is responsible for the shift. FRET uses the long range dipole-dipole interaction52
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Figure 6.3: Fluoresence shift in a ﬁlm of quantum dots.
to eﬀectively transfer energy between a ﬂuorophore to another one with a lower
energy state without emission and reabsorption. Since any sample of quantum dots
always has distribution of sizes, the energy transfer is between slightly smaller dots
to slightly larger dots.
FRET has be studied extensively in the CdSe quantum dots[71][72][73]. Biosen-
sors based on FRET have been demonstrated[74]. FRET has also been demon-
started as a way to pump CdSe quantum dots for light emitting devices[75][76][77].
The ability to transfer energy into and out of quantum dots nonradiatively has
proven to be very useful in the CdSe quantum dots, and may also be in the lead
salt quantum dots.
By spectrally resolving the ﬂuorescence from the quantum dot ﬁlms, energy
transfer can be conﬁrmed. The ﬁlms were created by ﬁrst putting the PbS quantum
dots in chloroform. Then the dots in chloroform where put onto a glass coverslip53
and the chloroform was allowed to evaporate. The data shown in the Figure 6.4
shows the lifetime at diﬀerent wavelengths. The data clearly shows energy transfer
from the high energy to the low energy wavelengths on a time scale of roughly 200
ns.
FRET is usually done between two distinct ﬂuorophores as was done in Refer-
ence [78][79][80]. The fact that FRET is happening in a distribution of ﬂuorophores
greatly complicates the analysis. A quantum dot can be both a donor and an ac-
ceptor. From the data at 920 nm (the center the emission of the solution) the
emitting dot is apparently is neither a net donor or acceptor. Nonetheless if the
single dot absorption and emission linewidths are known then a numerical analysis
of the data can be performed similar to the work done by Kagan and coworkers[72].
However, the single dot linewidths are not known well. Since the PbS data match
similar data for the CdSe quantum dots from Kagan and coworkers and other re-
search groups[72][73], the 40 nm luminescence shift and the 200 ns FRET transfer
time will be suﬃcient to describe this measurement.
In the interest of being able to calculate a F¨ orster radius, an experiment be-
tween two “distinct” sizes of quantum dots was performed similar to that done by
Kagan and coworkers[72]. While both samples will have a size distribution, they
will be approximated as two distinct ﬂuorophores. PbS quantum dots with ﬁrst
exciton peak at 770 nm and emission centered at 920 nm were mixed with PbS
quantum dots with ﬁrst exciton peak at 880 nm and emission centered at 1012 nm.
The overlap between the emission of the 770 nm quantum dots and the absorption
of the 880 nm quantum dots is shown in Figure 6.5.
The emission of the dots mixed in solvent (TCE) and dried on the ﬁlm are
shown in Figure 6.6. While in the solvent the emission of the combined dots shows54
0 0.5 1 1.5 2 2.5 3
Time (ms)
1
C
o
u
n
t
s
Lifetime of PbS QDs in Film
980 nm
940 nm
900 nm
860 nm
800 860 900 940 980 1100 1200
Wavelength (nm)
PbS QD in Solvent 920 nm
PbS QD Film 960 nm
Fluorescence PbS QD in Solvent and Film
Figure 6.4: Spectrally and time resolved ﬂuorescence of the quantum dot ﬁlm.55
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Figure 6.5: Overlap of the emission from the 770 nm qauntum dots with the
absorbance of the 880 nm quantum dots.
a superposition of the individual emission spectra, the dots dried in ﬁlm show
emission that looks similar to the emission of the 880 nm dots only. The shift in
luminescence is from 950 nm in solution by 100 nm to 1050 nm.
To calculate a F¨ orster radius, R0, the formula as followed is used[81].
R
6
0 =
9000κ2 ln10
128π6n4NAV
Φd
Z ∞
0
Ed(ν)²a(ν)
dν
ν4 (6.1)
κ2 is an orientation factor that is assigned 2/3. NAV is Avogadro’s number. Φd is
the quantum yield of the donor. Ed(ν) is the normalized donor emission spectra.
²a(ν) is the molar extinction coeﬃcient of the acceptor. There some uncertainity
in some of these numbers. The concentration is not known but is estimated from
the size of the quantum dots and the known mass of lead salt per mL. This gives
an estimated ²a at the ﬁrst exciton peak of 8×104M−1cm−1. The quantum yield is
taken to be around 50 % but it is not known. Given data from Reference [68], 50%56
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Figure 6.6: Fluorescence of the combination of dots in solvent (top) and in a ﬁlm
(bottom).57
is not unreasonable. The quantum yield is not easily measured for a ﬂuorophore
in the near infrared. The overlap integral is calculated with the absorption and
emission from Figure 6.5 with the assumption that there are only two ﬂuorophores.
The actual integral should be over the single particle absorption and emission. This
calculation is only to get a rough idea of the F¨ orster radius. With all the numbers
put into the equation a F¨ orster radius of 80˚ A is calculated. Note due to the
sixth power in the exponent, a 50% error in the calculation is only a 7˚ A error
in the radius. The calculated F¨ orster radius is within an order of magnitude of a
reasonable number.
Spectrally resolving the ﬂuorescence again shows the energy tranfer. The data
is shown in Figure 6.7. The transfer time appears to be between 200 and 400 ns.
The theoretical transfer time is given by the equation:
τ = τd
µ R
R0
¶6
(6.2)
In the equation τd is the lifetime of the donor taken to be 2.5 µs. This gives a
separation distance between 50 and 60 ˚ A. Even though the estimate is quite rough,
it gives a distance that is quite plausible for a close packed quantum dot ﬁlm.
Another way to look at the previous experiment is to think of the two dots
together not as two dots, but as one sample of dots with a large size distribution.
The much larger spectral shift ﬁts well with the calculated work done by Kagan
and coworkers[72]. A larger size distribution leads to a larger spectral shift.
6.4 Conclusion
The PbS quantum dots have long lifetimes, around 2 µs. Dielectric screening
can explain this fact, and dielectric screening can also help explain the lack of a58
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Figure 6.7: Spectrally and time resolved ﬂuorescence of the quantum dot ﬁlm.59
nonlinear signal measured. The PbS quantum dots exhibit FRET very similar to
the CdSe quantum dots. The FRET times are longer because the lifetimes are
longer. If more were known about the intrinsic properties of the PbS, then a more
detailed analysis similar to Kagan and coworkers[72] could be performed. It would
also be beneﬁcial if the lifetime of the dots in solvent were consistent between
samples produced at diﬀerent times.
While it is important to verify that FRET takes place in PbS ﬁlms and that
it is the cause of the luminescence shift, the there is no novelty in the observation
because it so closely mirrors the work done with the CdSe quantum dots. The
really interesting work is to use FRET to transfer energy into the quantum dots
from other sources similar to the work done by Klimov’s group [75][76] and by
Anni and coworkers[77]. Questions such how does dielectric screening aﬀect the
transfer times, and what eﬀect does the large diﬀerence in lifetimes between donor
and acceptor mean for applications, will have to be answered.
While the lead salt quantum dots do not look favorable as nonlinear materials,
the future of the lead salt quantum dots looks quite promising. Recent research
by other groups such as impact ionization in the lead salts that may lead to more
eﬃcient solar cells will help keep the ﬁeld strong for several more years[82].APPENDIX A
METHODS FOR ENCAPSULATING QUANTUM DOTS IN LIPIDS
A.1 Introduction
The encapsulating procedure is based roughly on the work of Dubertret and
coworkers [14]. It involves three main steps. Washing is performed to get rid
of excess ligand. Then the actual encapsulation step is next. Then a ﬁltering step
is performed last of all.
Unless otherwise noted, all lipids came from Avanti Polar Lipids of Alabaster,
Alabama. The quantum dots were donated by Professor Todd Krauss of Rochester
University. Care must be taken in using this synthesis with dots from other sources.
Coworkers in the Wise group lab, Byung-Ryool Hyun and Sareet Jacob[83], found
that to encapsulate quantum dots from Evident Technologies, ligand exchange had
to be performed.
A.2 Washing the Dots
Washing the dots is actually a method to remove the excess ligand, which is usually
trioctylphosphine oxide (TOPO), from solution. The dots are grown in a solution
that is rich in TOPO and they are usually stored and shipped in solution with
excess TOPO. The excess TOPO in the solution helps keep the dots stable over
several months. Therefore one should wash the dots only before they plan to
encapsulate them. Washed dots last at least a few weeks.
If the excess TOPO is not removed from the solution, the dots will not be
encapsulated. TOPO is very hydrophobic, and if there is excess, the lipids will
form micelles around the free TOPO and not the quantum dots. The result is
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a foamy solution of TOPO-lipid micelles and quantum dot aggregates. However,
washing the dots also can damage them. If the dots are washed too often, too
much TOPO will be removed from the dots. Then the dots will precipitate out
of the nonpolar organic solvents. The dots without the TOPO aren’t hydrophobic
enough, and won’t form a micelle. The water will then destroy them. Depending
on the source of quantum dots, one may have to wash the dots slightly diﬀerently
as diﬀerent sources may have diﬀering amounts of ligand with the quantum dots.
The basic concept of washing is that the dots are put into a slightly polar
solvent, methanol. Then the dots are centrifuged. The dots end up on the bottom
of the centrifuge tube and excess TOPO is left in solution which is then removed.
The precipitated quantum dots are then reintroduced to a nonpolar organic solvent.
If they haven’t been washed too many times, they will go back into solution. A
little experimentation may be required to get the washing correct when dealing
with a new source of quantum dots.
The quantum dots came from Professor Krauss in hexane at 15 µM. The dot to
slightly polar solvent ratio used in washing was 1 to 3. Since a microcentrifuge that
held 1.5 mL eppendorf tubes was used to precipitate the quantum dots, 700 µL of
dots were washed at a time. 350 µL of dots was mixed with 997.5 µL methanol
and 52.5 µL of butanol and put into a tube. On the advise of Professor Krauss
a small amount of butanol was used. Methanol by itself seemed to work ﬁne as
well though. The 1.4 mL of solution was put into two 1.5 mL eppendorf tubes.
The two tubes were put into the centrifuge opposite each other for balance. The
centrifuge was then run at 10,000 rpm for 5 minutes. After that, the dots were
at the bottom of the eppendorf tube. The solution was poured oﬀ, and 350 µL of
hexane was put into the tube. After a slight shake the quantum dots went back62
into solution. This step was performed three times and then the dots were stored
in a glass vial until they were used.
A.3 Encapsulating the Dots
Encapsulating the dots is quite straightforward. Washed dots were mixed with
the lipids which were in chloroform in a glass vial or test tube. The lipid to dot
ratio was around 2000 to 1. Then excess chloroform was added to the mixture.
The reason for the extra chloroform is that the dot lipid mixture when evaporated
must form a thin ﬁlm on the glass. If the ﬁlm is thick, the dots will be aggregated
when the water is added and usually stay that way. Typical numbers were 25 µL
of dots with 400 µL of excess chloroform plus whatever chloroform came with the
lipids. The actual amount of extra chloroform added depends on the glass tube
used. The extra 400 µL is for a 4 mL glass vial. If a diﬀerent glass tube or vial is
used, the extra chloroform needed may have to be adjusted.
The mixture is evaporated under nitrogen in a fume hood. Then clean water
at room temperature is added and the mixture is covered. The mixture is allowed
to sit at room temperature overnight. Temperature is expected to play a part in
the self-assembly of the lipid-dot micelles, but experimentally temperature didn’t
seem to matter much. It is worth more investigation though. The next day the
mixture was quickly, less than 30 seconds, ultrasonicated. Too much sonication
will also kill the dots. Then the dots are ready to be ﬁltered.
A table of lipid combinations that worked is listed in Table A.1. The ﬁrst
column is the amount of single chain lipid used. LMPC has a single 14 unit fully
saturated hydrocarbon chain with the phosphatidylcholine head group. The sec-
ond column is the double chain lipid used. DMPC has a double chain 14 units long63
Table A.1: Table of the diﬀerent combinations of lipids that produced single quan-
tum dot micelles.
5 % LMPC 5 % EDMPC 90 % SS
40 % LMPC 5 % DMPC 5 % EDMPC 50 % SS
50 % LMPC 40 % DMPC 5 % EDMPC 5 % SS
33 % LMPC 33 % DMPC 17 % EDMPC 17 % SS
50 % LMPC 50 % SS
40 % LMPC 40 % DLPC 20 % EDLPC
50 % LMPC 40 % DLPC 10 % DLPA
20 % LMPC 10 % EDLPC 70 % SS
and DLPC has a double chain 12 units long. Both have fully saturated hydrocar-
bon chains and have the phosphatidylcholine head group. The third column is the
charged lipid used. EDMPC and EDLPC are like DMPC and DLPC respectively
except the head group is ethylphosphatidylcholine. Ethylphosphatidylcholine has
the phosphate group neuralized so it is a positively charged head group. DLPA
is a 12 unit fully saturated double hydrocarbon chain lipid with the phosphatic
acid head group which is negatively charged. SS stands for sphingosine. The phos-
phatidylcholine lipids were used mainly because they are inexpensive compared
with lipids with other head groups.
A.4 Filtering the Dots
Although it is possible to have the lipids just right to encapsulate all the dots
into single dot micelles, often there will be a small percentage that form two or64
more dots per micelle. In order to get rid of the non-single dot micelles, ﬁltering is
performed. Syringe ﬁlters from Millipore were used. The membrane ﬁlters that ﬁt
into the syringe are disposable and the syringe is reusable. Two ﬁlters were used
from Millipore, one with 220 nm pore and the other with a 25 nm pore. Unless
the method of encapsulating is known to produce mostly single QD micelles, the
220 nm pore ﬁlter is used ﬁrst. This gets rid of any large aggregates that may
clog the smaller ﬁlter. Also these are 60% cheaper than the 25 nm pore ﬁlters. If
the quantum dots don’t go through this ﬁlter or are very diﬃcult to go through
this ﬁlter, then the lipid mixture won’t work. The smaller ﬁlter is then used. If a
substantial number of quantum dots go through the ﬁlter (and this is checked by
a ﬂuorometer or a UV lamp), then the encapsulation procedure worked.
Fluorescence correlation spectroscopy was performed both before and after the
ﬁltering on many samples. Only a few samples could have simple diﬀusion ﬁts
without ﬁltering. Most encapsulation procedures that worked often would have
one or two quantum dot aggregrates go through the diﬀusion volume in the ﬁve
minutes it took to take data. Only one aggregate is enough to alter the FCS curve.
With ﬁltering, the encapsulated quantum dots produce clean FCS curves.BIBLIOGRAPHY
[1] C. B. Murray, D. J. Norris, and M. G. Bawendi, J. Am. Chem. Soc. 115, 8706
(1993).
[2] C. B. Murray, S. H. Sun, W. Gaschler, et al., IBM J. Res.Dev. 45, 47 (2001).
[3] S. Kim and M. G. Bawendi, J. Am. Chem. Soc. 125, 14652 (2003).
[4] H. Mattoussi, J. M. Mauro, E. R. Goldman, G. P. Anderson, V. C. Sundar,
F. V. Mikulec, and M. G. Bawendi, J. Am. Chem. Soc. 122, 12142 (2000).
[5] A. L. Efros and A. L. Efros, Sov. Phys. Semicond. 16, 772 (1982).
[6] L. E. Brus, J. Chem. Phys. 80, 4403 (1984).
[7] S. Schmitt-Rink, D. A. B. Miller, and D. S. Chemla, Phys. Rev. B 35, 8113
(1987).
[8] M. Brumer, A. Kigel, L. Amirav, A. Sashchiuk, O. Solomesch, N. Tessler, and
E. Lifshitz, Adv. Funct. Mater. 15, 1111 (2005).
[9] S. M. Sze, Physics of Semiconductor Devices (Wiley, New York, 1981).
[10] M. A. Hines and P. Guyot-Sionnest, J. Phys. Chem. 100, 468 (1996).
[11] X. Peng, J. Wickham, and A. P. Alivisatos, J. Am. Chem. Soc. 120, 5343
(1998).
[12] M. Bruchez Jr., M. Moronne, P. Gin, S. Weiss, and A. P. Alivisatos, Science
281, 2013 (1998).
[13] W. C. W. Chan and S. Nie, Science 281, 2016 (1998).
[14] B. Dubertret, P. Skourides, D. J. Norris, V. Noireaux, A. H. Brrivanlou, and
A. Libchaber, Science 298, 1759 (2002).
[15] W. C. W. Chan, D. J. Maxwell, X. Gao, R. E. Bailey, M. Han, and S. Nie,
Curr. Opin. Biotechnol. 13, 40 (2002).
[16] V. L. Colvin and A. P. Alivisatos, J. Chem. Phys. 97, 730 (1992).
[17] V. L. Colvin, K. L. Cunningham, and A. P. Alivisatos, J. Chem. Phys. 101,
7122 (1994).
[18] V. L. Colvin, Ph.D. thesis, University of California at Berkeley, 1994.
[19] S. A. Empedocles and M. G. Bawendi, Science 278, 2114 (1997).
6566
[20] X. Wu, H. Liu, J. Liu, K. N. Haley, J. A. Treadway, J. P. Larson, N. Ge,
F. Peale, and M. P. Bruchez, Nature Biotechnol. 21, 41 (2003).
[21] M. Nirmal, B. O. Dabbousi, M. G. Bawendi, J. J. Macklin, J. K. Trautman,
T. D. Harris, and L. E. Brus, Nature 383, 802 (1996).
[22] D. R. Larson, W. R. Zipfel, R. M. Williams, S. W. Clark, M. P. Bruchez,
F. W. Wise, and W. W. Webb, Science 300, 1434 (2003).
[23] D. R. Larson, Ph.D. thesis, Cornell University, 2004.
[24] W. W. Webb, Appl. Opt. 40, 3969 (2001).
[25] H. Mattoussi, A. W. Cumming, C. B. Murray, M. G. Bawendi, and R. Ober,
Phys. Rev. B 58, 7850 (1998).
[26] M. Pelton, D. G. Grier, and P. Guyot-Sionnest, Appl. Phys. Lett. 85, 819
(2004).
[27] M. Kuno, D. P. Fromm, H. F. Hamann, A. Gallagher, and D. J. Nesbitt, J.
Chem. Phys. 112, 3117 (2000).
[28] T. J. Rink, C. Montecucco, T. R. Hesketh, and R. Y. Tsien, Biochim. Biophys.
Acta 595, 15 (1980).
[29] E. F. Fluhler, V. G. Burnham, and L. M. Loew, Biochemistry 24, 5749 (1985).
[30] H. T. Tien, Bilayer Lipid Membranes (BLM): Theory and Practice (Dekker,
New York, 1974).
[31] L. Moreaux, T. Pons, V. Dambrin, M. Blanchard-Desce, and J. Mertz, Opt.
Lett. 28, 625 (2003).
[32] L. Mathivet, S. Cribier, and P. E. Devaux, Biophys. J. 70, 1112 (1996).
[33] K.-i. Akashi, H. Miyata, H. Itoh, and K. Kinosita Jr., Biophys. J. 71, 3242
(1996).
[34] T. J. Rink, C. Montecucco, T. R. Hesketh, and R. Y. Tsien, Biochim. Biophys.
Acta 595, 15 (1980).
[35] C. Bronner and Y. Landry, Biochim. Biophys. Acta 1070, 3321 (1991).
[36] A. H. Merill, Jr., E-M. Schmelz, D. L. Dillehay, S. Spiegel, J. A. Shayman,
J. J. Schroeder, R. T. Riley, K. A. Voss, and E. Wang, Toxicology and Applied
Pharmacology 142, 208 (1997).
[37] J. N. Israelachvili, Intermolecular and Surface Forces (Academic Press, Or-
lando, 1985), pp. 229-275.67
[38] K. Holmberg, B. J¨ onsson, B. Kronberg, and B. Lindman, Surfactants and
Polymers in Aqueous Solution (John Wiley & Sons, Ltd, West Sussex, England,
2003).
[39] C. Tanford, The Hydrophobic Eﬀect: Formation of Micelles and Biological
Membranes (Wiley, New York 1980).
[40] D. Marsh, CRC Handbook of Lipid Bilayers (CRC Press, Boca Raton, FL,
1990), p. 276-279.
[41] K. Sou, T. Endo, S. Takeoka, and E. Tsuchida, Bioconjugate Chem. 11, 372
(2000).
[42] H. Heerklotz and R. M. Epand, Biophys. J. 80, 271 (2001).
[43] J. Eastoe and J. S. Dalton, Langmuir 14, 5719 (1998).
[44] D. S. Johnston, S. Sanghera, M. Pons, and D. Chapman, Biochim. Biophys.
Acta 602, 57 (1980).
[45] Y. Kang and T. A. Taton, J. Am. Chem. Soc. 125, 5650 (2003).
[46] R. C. MacDonald, G. W. Ashley, M. M. Shida, V. A. Rakhmanova, Y. S. Tara-
hovsky, D. P. Pantazatos, M. T. Kennedy, E. V. Pozharski, K. A. Baker,
R. D. Jones, H. S. Rosenzweig, K. L. Choi, R. Qui, and T. J. McIntosh, Biophys.
J. 77, 2612 (1999).
[47] D. A. Dombeck, M. B.-Desce, and W. W. Webb, J. Neurosci. 24, 999 (2004).
[48] M. Han, X. Gao, J. Z. Su, and S. Nie, Nature Biotechnol. 19, 631 (2001).
[49] Landolt-Bornstein: Numerical Data and Functional Relationships in Science
and Technology, New Series edited by O. Madelung, M. Schultz, and H. Weiss
(Springer-Verlag, 1982).
[50] F. W. Wise, Acc. Chem. Res. 33, 773 (2000).
[51] I. Kang and F. W. Wise, J. Opt. Soc. Am. B 14, 1632 (1997).
[52] G. Allan and C. Delerue, Phys. Rev. B 70, 245321 (2004).
[53] L. E. Brus, Appl. Phys. A 53, 465 (1991).
[54] V. Klimov in Handbook on Nanostructured Materials and Nanotechnology,
H. Nalwa, ed., (Academic Press, San Diego, CA, 1999) Volume 4, p 451.
[55] M. Yamane and Y. Asahara, Glasses for Photonics (Cambridge University
Press, Cambridge, United Kingdom, 2000).68
[56] P. T. Guerreiro, S. Ten, N. F. Borrelli, J. Butty, G. E. Jabbour, and
N. Peyghambarian, Appl. Phys. Lett. 71, 1595 (1997).
[57] K. Wundke, S. P¨ otting, J. Auxier, A. Sch¨ ulzgen, N. Peyghambarian, and
N. F. Borelli, Appl. Phys. Lett. 76, 10 (2000).
[58] J. F. Philipps, T. T¨ opfer, H. Ebendorﬀ-Heidepriem, D. Ehrt, R. Sauerbrey,
and N. F. Borrelli, Appl. Phys. B 72 175 (2001).
[59] A. M. Malyarevich, V. G. Savitski, P. V. Prokoshin, N. N. Posnov, K. V. Yu-
mashev, E. Raaben, and A. A. Zhilin, J. Opt. Soc. Am. B 19 28 (2002).
[60] G. P. Agrawal, Nonlinear Fiber Optics (Academic Press, San Diego, California
1995) p 583.
[61] M. Sheik-Bahae, A. A. Said, T.-H. Wei, D. J. Hagan, and E. W. Van Stryland,
IEEE J. Quantum Electron. 26, 760 (1990).
[62] I. Kang, T. Krauss, and F. Wise, Opt. Lett. 22, 1077 (1997).
[63] C. H. Kwak, Y. L .Lee, and S. G. Kim, J. Opt. Soc. Am. B 16, 600 (1999).
[64] M. Falconieri, J. Opt. A: Pure Appl. Opt. 1, 662 (1999).
[65] S. Alves, A. Bourdon, and A. M. Figueiredo Neto, J. Opt. Soc. Am. B 20,
713 (2003).
[66] J. Wang, M. Sheik-Bahae, A. A. Said, D. J. Hagan, and E. W. Van Stryland,
J. Opt. Soc. Am. B 11, 1009 (1994).
[67] J. M. Harbold, F. ¨ O. Ilday, F. W. Wise, J. S. Sanghera, V. Q. Nguyen,
L. B. Shaw, and I. D. Aggarwal, Opt. Lett. 27, 119 (2002).
[68] B. L. Wehrenberg, C. Wang, and P. Guyot-Sionnest, J. Phys. Chem. B 106,
10634 (2002).
[69] S. F. Wuister, C. de Mello Donega, and A. Meijerink, J. Chem. Phys. 121,
4310 (2004).
[70] J. H. Warner, E. Thomsen, A. R. Watt, N. R. Heckenberg, and H. Rubinsztein-
Dunlop, Nanotechnology 16, 175 (2005).
[71] C. R. Kagan, C. B. Murray, M. Nirmal and M. G. Bawendi, Phys. Rev. Lett.
76, 1517 (1996).
[72] C. R. Kagan, C. B. Murray, and M. G. Bawendi, Phys. Rev. B 54, 8633
(1996).
[73] S. A. Crooker, J. A. Hollingsworth, S. Tretiak, and V. I. Klimov, Phys. Rev.
Lett. 89, 186802 (2002).69
[74] I. L. Medintz, A. R. Clapp, H. Mattoussi, E. R. Goldman, B. Fisher, and
J. M. Mauro, Nature Materials 2, 630 (2003).
[75] M. Achermann, M. A. Petruska, S. Kos, D. L. Smith, D. D. Koleske, and
V. I. Klimov, Nature 429, 642 (2004).
[76] S. Kos, M. Achermann, V. I. Klimov, and D. L. Smith, Phys. Rev. B 71,
205309 (2005).
[77] M. Anni, L. Manna, R. Cingolani, D. Valerini, A. Creti, and M. Lomascolo,
Appl. Phys. Lett 85, 4169 (2004).
[78] R. C. Powell and R. G. Kepler, Phys. Rev. Lett. 22, 636 (1969).
[79] P. Wu and L. Brand, Anal. Biochem. 218, 1 (1994).
[80] R. M. Clegg, Curr. Opin. Biotechnol. 6, 103 (1995).
[81] T. F¨ orster, Discuss. Faraday Soc. 27, 7 (1959).
[82] R. D. Schaller and V. I. Klimov, Phys. Rev. Lett. 92, 186601 (2004).
[83] B.-R. Hyun and S. Jacob (private communication).